MCPHERSON'S LIMITED (MCP)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

MCP - MCPHERSON'S LIMITED

FNArena Sector : Health & Nutrition

Year End: June

GICS Industry Group : Consumer Durables & Apparel

Index: ALL-ORDS

LAST PRICE	CHANGE +/-	CHANGE %	VOLUME
$1.07 21 Sep 2021	0.000 OPEN $1.07	0.000 HIGH $1.09	216,653 LOW $1.07

LAST PRICE

CHANGE +/-

CHANGE %

VOLUME

$1.07

21 Sep
2021

0.000

OPEN

$1.07

0.000

HIGH

$1.09

216,653

LOW

$1.07

TARGET
$1.20 12.1% upside
Franking for last dividend paid out: 100%

OTHER COMPANIES IN THE SAME SECTOR
EBO . API . BKL . EXL . SIG . CLV .

FNARENA'S MARKET CONSENSUS FORECASTS

Title	FY20 Actual	FY21 Actual	FY22 Forecast	FY23 Forecast
EPS (cps)	xxx	- 4.2	7.8	xxx
DPS (cps)	xxx	165.0	6.0	xxx
EPS Growth	xxx	N/A	N/A	xxx
DPS Growth	xxx	100.0%	- 96.4%	xxx
PE Ratio	xxx	N/A	13.7	xxx
Dividend Yield	xxx	N/A	5.6%	xxx
Div Pay Ratio(%)	xxx	N/A	76.9%	xxx

Dividend yield today if purchased 3 years ago: 111.49%

DIVIDEND YIELD CALCULATOR

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 03/09 - 1.5c (100%)

HISTORICAL DATA ARE ALL IN AUD

Copyright © 2021 FactSet UK Limited. All rights reserved

Title	2016	2017	2018	2019	2020	2021
EPS Basic	xxx	xxx	xxx	xxx	xxx	-4.2
DPS All	xxx	xxx	xxx	xxx	xxx	165.0
Sales/Revenue	xxx	xxx	xxx	xxx	xxx	200.5 M
Book Value Per Share	xxx	xxx	xxx	xxx	xxx	89.5
Net Operating Cash Flow	xxx	xxx	xxx	xxx	xxx	2.7 M
Net Profit Margin	xxx	xxx	xxx	xxx	xxx	-2.51 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title	2016	2017	2018	2019	2020	2021
Return on Assets	xxx	xxx	xxx	xxx	xxx	-2.58 %
Return on Equity	xxx	xxx	xxx	xxx	xxx	-4.91 %
Return on Total Capital	xxx	xxx	xxx	xxx	xxx	1.04 %
Capex	xxx	xxx	xxx	xxx	xxx	2.5 M
Capex % of Sales	xxx	xxx	xxx	xxx	xxx	1.26 %
Free Cash Flow ex dividends	xxx	xxx	xxx	xxx	xxx	-9.5 M

Return on Assets

Return on Equity

Return on Total Capital

Capex

Capex % of Sales

Free Cash Flow ex dividends

This is work in progress. Bear with us. It'll be amazing.

EXPERT VIEWS

Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

BROKER	DATE	RATING	RECOMMENDATION	TARGET PRICE	% TO REACH TARGET	COMMENTARY
Ord Minnett	19/08/2021	3	Hold	$1.20	12.15%	McPherson's reported underlying earnings (EBIT) and EPS in-line with the prior guidance range provided to the market. Current lock-down restrictions are thought likely to be impeding sales in the pharmacy categories. As a result, the broker adopts a conservative approach to FY22 estimates and reduces its target price to $1.20 from $1.42, while retaining its Hold rating. The fully franked dividend yield of 5%-6% supports the share price at current levels, in the broker's view. It's thought further corporate interest from industry and financial buyers is possible. FORECAST Ord Minnett forecasts a full year FY22 dividend of 6.00 cents and EPS of 7.80 cents. Ord Minnett forecasts a full year FY23 dividend of 6.50 cents and EPS of 8.50 cents.

BROKER

DATE

RATING

RECOMMENDATION

TARGET PRICE

% TO REACH TARGET

COMMENTARY

Ord Minnett

19/08/2021

Hold

$1.20

12.15%

McPherson's reported underlying earnings (EBIT) and EPS in-line with the prior guidance range provided to the market. Current lock-down restrictions are thought likely to be impeding sales in the pharmacy categories.

As a result, the broker adopts a conservative approach to FY22 estimates and reduces its target price to $1.20 from $1.42, while retaining its Hold rating.

The fully franked dividend yield of 5%-6% supports the share price at current levels, in the broker's view. It's thought further corporate interest from industry and financial buyers is possible.

FORECAST
Ord Minnett forecasts a full year FY22 dividend of 6.00 cents and EPS of 7.80 cents.
Ord Minnett forecasts a full year FY23 dividend of 6.50 cents and EPS of 8.50 cents.

Access Stockbroker Research History >

MCP STOCK CHART

FNArena News on MCP

1	FNArena Corporate Results Monitor – 19-08-2021 Aug 19 2021 - Australia

2	Australian Broker Call Extra Edition – May 26, 2021 May 26 2021 - Daily Market Reports

3	Weekly Ratings, Targets, Forecast Changes – 02-04-21 Apr 06 2021 - Weekly Reports

4	Australian Broker Call Extra Edition – Mar 31, 2021 Mar 31 2021 - Daily Market Reports

5	Australian Broker Call Extra Edition – Mar 09, 2021 Mar 09 2021 - Daily Market Reports

Latest Health & Nutrition News

1	Health & Wellness Boom On The ASX Apr 29 2021 - Weekly Reports

2	M&A Now On Sigma Healthcare’s Agenda Mar 24 2021 - Australia

3	McPherson’s Expands Into Herbal Health Nov 04 2020 - Small Caps

4	Nine Ignored Companies Now Worth A Look Sep 23 2020 - FYI

5	Next Week At A Glance – 14-18 Sep 2020 Sep 11 2020 - Weekly Reports

6	Sigma Farewells API, Heralds New Contract Dec 17 2019 - Australia

7	Blackmores: Hopes Pinned On Restructuring Nov 01 2019 - Australia

8	Blackmores Peps Up Its Strategy For China Apr 17 2019 - Australia

9	API/Sigma Merger Plan Rears, Again Dec 17 2018 - Australia

10	Uncertainty Hinders Sigma Pharmaceuticals Sep 11 2018 - Small Caps

Dividend Yield Today On Last Actual Payout :	154.21
Estimated Dividend Growth (Average Of Past Three Years)	%
Amount Invested	$
Tell Me The Dividend After This Many Years

	Yield	Yield on investment
This Year
Year 1
Year 2
Year 3
Year 4
Year

1	FNArena Corporate Results Monitor – 19-08-2021 Aug 19 2021 - Australia

2	Australian Broker Call Extra Edition – May 26, 2021 May 26 2021 - Daily Market Reports

3	Weekly Ratings, Targets, Forecast Changes – 02-04-21 Apr 06 2021 - Weekly Reports

4	Australian Broker Call Extra Edition – Mar 31, 2021 Mar 31 2021 - Daily Market Reports

5	Australian Broker Call Extra Edition – Mar 09, 2021 Mar 09 2021 - Daily Market Reports

Get 2 Weeks free trial

Sign Up

Member Login

MCPHERSON'S LIMITED (MCP)
Share Price Analysis and Chart